Carregant...
Lurasidone Ingestions Reported to Texas Poison Centers
Background: Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia in 2010. There is limited information on potentially toxic events involving lurasidone outside of clinical investigations. Objective: This investigation describes potentially toxic lurasidone ingestions f...
Guardat en:
| Publicat a: | J Pharm Technol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990146/ https://ncbi.nlm.nih.gov/pubmed/34860899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514533305 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|